SCHEMBL14829610

SCHEMBL14829610

[CH2]c1c(-c2cc3ccccc3[nH]2)[nH]c2ccccc12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.52
NPC1 O15118 3/20 0.52
ITK Q08881 3/20 0.50
TUBB4A P04350 1/20 0.47
TUBB P07437 1/20 0.47
TUBA3C P0DPH7 1/20 0.47
TUBA1B P68363 1/20 0.47
TUBA4A P68366 1/20 0.47
TUBB4B P68371 1/20 0.47
TUBB3 Q13509 1/20 0.47
TUBB2A Q13885 1/20 0.47
TUBB8 Q3ZCM7 1/20 0.47
TUBA3E Q6PEY2 1/20 0.47
TUBA1A Q71U36 1/20 0.47
TUBA1C Q9BQE3 1/20 0.47
TUBB6 Q9BUF5 1/20 0.47
TUBB2B Q9BVA1 1/20 0.47
TUBB1 Q9H4B7 1/20 0.47
KDM4E B2RXH2 4/20 0.46
MAPT P10636 4/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2045033 0.80 RAB9A (0.53) RAB9ANPC1ITKTUBB4ATUBB
SCHEMBL31555117 0.80 RAB9A (0.53) RAB9ANPC1ITKTUBB4ATUBB
SCHEMBL374022 0.76 RAB9A (0.74) RAB9ANPC1ITKKDM4EMAPT
SCHEMBL29631691 0.76 RAB9A (0.74) RAB9ANPC1ITKKDM4EMAPT
SCHEMBL11363931 0.75 KDR (0.63) RAB9ANPC1ITKKDM4EMAPT
SCHEMBL10176240 0.73 KDR (0.61) RAB9ANPC1ITKKDM4EMAPT
2-Phenyl-1H-Indole SCHEMBL18059783 0.73 NPC1 (0.81) RAB9ANPC1ITKTUBB4ATUBB
SCHEMBL2476987 0.71 CHEK1 (0.54) RAB9ANPC1ITKKDM4EMAPT
SCHEMBL13650110 0.71 ITK (0.58) RAB9ANPC1ITKTUBB4ATUBB
SCHEMBL646937 0.71 RAB9A (0.47) RAB9ANPC1ITKTUBB4ATUBB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2760446-A1 SMAC MIMETIC (BIRINAPANT) FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES (CANCER) TETRALOGIC PHARMACEUTICALS CORPORATION (US) 2014-08-06 EP disclosed
WO-2013049350-A1 SMAC MIMETIC (BIRINAPANT) FOR USE IN THE TREATMENT OF PROLIFERATIVE DISEASES (CANCER) TETRALOGIC PHARMACEUTICALS CORPORATION (US) 2013-04-04 WO disclosed